STAND: 3A54
Biosynex was founded in 2005 and specialises in the design and sale of rapid tests. Biosynex is now the French market leader in this field. Fast and easy to use, these tests are sold in France and over 90 other countries through various distribution networks (pharmacies, laboratories, hospitals, etc.). By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.The professional versions of our rapid test kits give fast results and are easy to use, thus ensuring better medical care for patients. Our self test kits allow the public to monitor a number of conditions by themselves, thereby guaranteeing better prevention and earlier identification of a need for treatment. Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR). Biosynex manages the entire value chain for all its rapid tests, from design to market.
